НовостиBenzingaRaymond James Initiates Coverage On Seaport Therapeutics with Strong Buy Rating, Announces Price Target of $46 Raymond James Initiates Coverage On Seaport Therapeutics with Strong Buy Rating, Announces Price Target of $46 Benzinga 2026.09.25 11:23 (GMT+0) Открыть на Benzinga Другие новости